Zealand Pharma
Developing innovative peptide medicines for metabolic and inflammatory diseases.
ZEAL | CO
Overview
Corporate Details
- ISIN(s):
- DK0060257814 (+2 more)
- LEI:
- 549300ITBB1ULBL4CZ12
- Country:
- Denmark
- Address:
- Sydmarken 11, 2860 Søborg
- Website:
- https://www.zealandpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Zealand Pharma is a biotechnology company specializing in the discovery, design, and development of innovative peptide-based medicines. With over 25 years of expertise in peptide engineering, the company focuses on creating next-generation therapeutics for metabolic and inflammatory diseases. Its clinical pipeline targets conditions with significant unmet medical needs, including obesity, congenital hyperinsulinism, short bowel syndrome, and chronic autoimmune diseases. Key programs involve novel peptide analogs such as amylin, long-acting GLP-2, and dual agonists for GLP-1/GLP-2 and glucagon/GLP-1 receptors. The company advances its portfolio through both proprietary development and strategic partnerships with major pharmaceutical firms.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-17 17:05 |
Major Shareholding Notification
|
English | 5.6 KB | ||
| 2025-10-17 17:05 |
Major Shareholding Notification
|
English | 553.9 KB | ||
| 2025-10-17 17:05 |
Major Shareholding Notification
|
English | 377.4 KB | ||
| 2025-09-30 17:05 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 5.6 KB | ||
| 2025-09-11 22:00 |
Share Issue/Capital Change
|
English | 5.9 KB | ||
| 2025-08-20 22:00 |
Major Shareholding Notification
|
English | 5.6 KB | ||
| 2025-08-20 22:00 |
Major Shareholding Notification
|
English | 550.7 KB | ||
| 2025-08-20 22:00 |
Major Shareholding Notification
|
English | 367.5 KB | ||
| 2025-08-14 07:00 |
Earnings Release
|
English | 25.7 KB | ||
| 2025-08-14 07:00 |
Earnings Release
|
English | 891.1 KB | ||
| 2025-07-18 18:30 |
Major Shareholding Notification
|
English | 301.0 KB | ||
| 2025-07-18 18:30 |
Major Shareholding Notification
|
English | 5.6 KB | ||
| 2025-07-18 18:30 |
Major Shareholding Notification
|
English | 516.4 KB | ||
| 2025-06-30 17:05 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 5.6 KB | ||
| 2025-06-18 17:29 |
Regulatory News Service
|
English | 14.1 KB |
Automate Your Workflow. Get a real-time feed of all Zealand Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Zealand Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Zealand Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
